| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.1M | — | +95.0% |
| SG&A Expense | $1.3M | — | -8.0% |
| Operating Income | -$2.4M | — | -22.4% |
| Pre-tax Income | -$2.4M | — | -27.7% |
| Net Income | -$2.4M | — | -27.7% |
| EPS (Basic) | -$0.28 | — | -27.3% |
| EPS (Diluted) | -$0.28 | — | -27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.4M | -52.5% | -83.0% |
| Current Assets | $2.1M | -46.9% | -77.8% |
| Total Assets | $4.0M | -32.7% | -65.1% |
| Current Liabilities | $1.6M | +1.0% | +9.6% |
| Total Liabilities | $2.5M | -3.2% | -5.8% |
| Stockholders' Equity | $1.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | -34.5% |
| Capital Expenditures | $58K | — | +85.5% |
| Investing Cash Flow | -$58K | — | -85.5% |
| Financing Cash Flow | -$13K | — | +70.6% |
| Free Cash Flow | -$1.6M | — | -35.8% |
| -82.8% |